Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / January 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MiMedx Group, Inc. ("MiMedx" or "the Company") (NASDAQ:MDXG). Investors who purchased MiMedx securities are encouraged to obtain additional informatio...
Boston, Massachusetts--(Newsfile Corp. - January 3, 2024) - Block & Leviton is investigating MiMedx Group, Inc. (NASDAQ: MDXG) for potential securities law violations. Investors who have lost money in their MiMedx Group, Inc. investment should contact the firm to learn more about how t...
2023-12-29 18:01:59 ET More on MiMedx Group MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript Unraveling MiMedx's Surgical Precision In Growth MiMedx adds 30M shares on conversion of preferred stock MiMedx Group Non-GAAP EPS of $0.05 in-line, revenue...
Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety Request for Designation for AXIOFILL Submitted to FDA and Currently Under Review Reiterates Expectations for 2023 Net Sales Growth in the High Teens and Fourth Quarter Adjusted EBITDA Margin of Abov...
2023-12-28 08:30:35 ET More on MiMedx Group MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript Unraveling MiMedx's Surgical Precision In Growth MiMedx Group Non-GAAP EPS of $0.05 in-line, revenue of $81.71M beats by $3.77M Seeking Alpha’s Quant...
MARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”), together with any accrued di...
2023-12-18 01:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MARIETTA, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum Capital Group 14 th ...
MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place November 2-5 in...
2023-10-30 21:17:07 ET MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call October 30, 2023 4:30 PM ET Company Participants Matt Notarianni - Head, Investor Relations Joseph H. Capper - Chief Executive Officer Doug Rice - Chief Financial Officer Conference Call...
News, Short Squeeze, Breakout and More Instantly...
Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management to Host Conference Call Today, April...
LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...
MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, April 3...